Skip to main content

Novel study finds aspirin-free regimen benefits patients with LVAD

November 27, 2023
The ARIES-HM3 Randomized Clinical Trial assessed the safety and efficacy of excluding aspirin from the antithrombotic regimen in patients with advanced heart failure who have undergone implantation of a fully magnetically levitated left ventricular assist device (LVAD). “There has been no consensus in the field about use of or dose...

Buse, Smith Recognized in Global Highly Cited Researchers 2023 List

November 22, 2023
John Buse, MD, PhD, and Sidney Smith Jr., MD, along with 18 UNC School of Medicine and 21 other UNC-Chapel Hill researchers have been named in Clarivate’s 2023 list of Highly Cited Researchers™. These scientific pioneers from around the world are drawn from the publications that rank in the top...

UME Faculty Spotlight: Duncan Vincent, MD

November 18, 2023
I am a former UNC resident and chief resident, now a clinical assistant professor in the DOM and working for Piedmont AHEC at Cone Health in Greensboro. I serve as the Associate Program Director for the Cone Internal Medicine Residency Program, a community-based residency program focused on training general medicine...

Can you get HIV from someone on PrEP? Rosengren-Hovee answers common question

November 17, 2023
Lina Rosengren-Hovee, MD, MPH, MS, was interviewed for a story that answers a common question about HIV and PrEP. “Can You Get HIV From Someone on PrEP?” was published in The Body. Rosengren said the odds for transmitting or acquiring an HIV infection are unlikely. “When we start people on...

UNC Hospitalists Publish Case Study on Hydralazine-Induced Anti-Neutrophil Cytoplasmic Antibody (ANCA) Vasculitis

November 17, 2023
The article describes a medical case involving an 82-year-old woman who was taking a medication called hydralazine for heart problems.

Nelson Expresses Concern for Use of Methotrexate in Hand OA Following Clinical Trial

November 16, 2023
"Many individuals with hand OA have multiple medical comorbidities and polypharmacy, which are important when considering additional treatments, particularly those with modest benefit and potential adverse effects over the long term," she said.

Isaacs Named Master of the American College of Gastroenterology

November 15, 2023
Kim Isaacs, MD, PhD, was designated as a “Master of the American College of Gastroenterology” (MACG), a prestigious recognition within the field of gastroenterology. She received the honor at this year’s American College of Gastroenterology (ACG) meeting in Vancouver Canada. The title of “Master” is an honorary designation granted by...

Basch Marks 10th Year as Associate Editor for JAMA

November 14, 2023
Ethan Basch, MD, MSc, is celebrating a remarkable milestone, marking his 10th year as an Associate Editor for the Journal of the American Medical Association (JAMA). Throughout the past decade, Dr. Basch has played a pivotal role as an oncology editor for JAMA, contributing significantly to the field of medical...

Moon wins Shark Tank Competition at The Liver Meeting 2023

November 13, 2023
Andrew Moon, MD, MPH, assistant professor of medicine in the Division of Gastroenterology and Hepatology, won the the American Association for the Study of Liver Disease (AASLD) Liver Cancer SIG Shark Tank Competition. At The Liver Meeting 2023 he presented a proposal for remote monitoring of decompensation symptoms (ePROs).

Participate in Thanksgiving 5K to honor patient and provide holiday presents to UNC Children’s Hospital patients

November 7, 2023
Contact Dr. Jennifer McEntee with questions. 

UNC Hemophilia Treatment Center hosts 6th NC HTC Pharmacy Summit

November 7, 2023
  Clinicians and staff from Hemophilia Treatment Centers (HTC) across the state, the Hemophilia Alliance, and UNC HTC Pharmacy recently joined together at the University of North Carolina for the 6th NC HTCPharmacy summit. The meeting provided networking and educational opportunities as well as a platform to discuss ways patient...

Department of Medicine Grants & Funding: October 1 – October 31, 2023

November 6, 2023
Division of Infectious Diseases Edward P Browne, PhD, received a: R61 grant  from the NIDA to examine the impact of cannabinoids in HIV infected humanized mice. This is a five year, $3,465,157 grant. R21 grant from the NIAID to examine post therapy changes in CD4 T cells by single cell...